NGHIÊN CỨU GỐC (ORIGINAL PAPERS)

Trends in the development of diagnostic methods for detectingBurkholderia pseudomallei (2010-2025): A global and Vietnamese perspective

DOI: https://doi.org/10.38148/JHDS.0901SKPT25-119 ↗
Hieu Bui Ngoc1, Anh Ho Quoc2, Truong Le Hong3, Quan Duong Hong4
1 Trường Đại học Y tế công cộng
2 Trường Đại học Y tế công cộng
3 Trường Đại học Y tế công cộng
4 Trường Đại học Y tế công cộng

Tóm tắt

Objectives: To describe the global and national trends in the development of diagnostic methods for detecting Burkholderia pseudomallei (B. pseudomallei) and to analyze the diagnostic performance of these detection methods during the period 2010-2025.

Subjects: Published studies and reports on diagnostic methods for B. pseudomallei conducted worldwide and in Vietnam from 2010 to 2025.

Methods: A systematic literature review was performed using PubMed and Google Scholar databases. A total of 34 eligible studies were included. Data was synthesized and analyzed using Microsoft Excel and Google Sheets and reference management was conducted with Zotero 7.0.

Results: Between 2010 and 2025, diagnostic approaches for B. pseudomallei were classified into four main categories: Culture-based methods, molecular biology techniques, Matrix-Assisted Laser Desorption/Ionization - Time of Flight (MALDI-TOF) mass spectrometry, and immunological assays. Immunoassays were the most widely applied due to their speed and low cost, though sensitivity and specificity varied. Culture-based methods remained indispensable as the diagnostic gold standard, despite moderate sensitivity and longer turnaround time. Molecular biology techniques, particularly Polymerase Chain Reaction (PCR) and Loop-Mediated Isothermal Amplification (LAMP) achieved high sensitivity and specificity, capable of detecting B. pseudomallei at very low DNA concentrations. MALDI-TOF mass spectrometry demonstrated nearly perfect accuracy in species identification from cultured colonies.

Conclusions: Diagnostic methods for B. pseudomallei have progressively evolved toward more rapid and precise technologies. Immunoassays are appropriate for preliminary screening, while culture remains essential for confirmation. Molecular biology- and MALDI-TOF-based techniques provide high accuracy and reliability, representing the future direction for diagnostic standardization and clinical application.

Đã Xuất bản 2026-02-28
Toàn văn
PDF
Ngôn ngữ Tiếng Việt
Số Tập 10 Số 01 (2026): Tập 10, Số 01-2026
Chuyên mục Nghiên cứu gốc (Original papers)
DOI https://doi.org/10.38148/JHDS.0901SKPT25-119 ↗
Trang số 27-39
Từ khóa
Keywords: B. pseudomallei diagnostic methods melioidosis global Vietnamese

Cách trích dẫn

Bui Ngoc, H., Ho Quoc, A., Le Hong, T., & Duong Hong, Q. (2026). Trends in the development of diagnostic methods for detectingBurkholderia pseudomallei (2010-2025): A global and Vietnamese perspective. Tạp Chí Khoa học Nghiên cứu Sức khỏe Và Phát triển, 10(01), 27-39. https://doi.org/10.38148/JHDS.0901SKPT25-119
  1. 1. Wiersinga WJ, Virk HS, Torres AG, et al. Melioidosis. Nat Rev Dis Primers. 2018;4(1):17107.
  2. 2. Lau SK, Sridhar S, Ho CC, et al. Laboratory diagnosis of melioidosis: Past, present and future. Exp Biol Med (Maywood). 2015;240(6):742–51.
  3. 3. Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents. 2014;43(4):310–8.
  4. 4. Limmathurotsakul D, Golding N, Dance DAB. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1(1):15008.
  5. 5. Limmathurotsakul D, Jamsen K, Arayawichanont A. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One. 2010;5(8):e12485.
  6. 6. Gassiep I, Armstrong M, Norton RE. Identification of Burkholderia pseudomallei by Use of the Vitek Mass Spectrometer. J Clin Microbiol. 2019;57(5):e00081-19.
  7. 7. Saxena A, Pal V, Tripathi NK, et al. A recombinase polymerase amplification lateral flow assay for rapid detection of Burkholderia pseudomallei, the causative agent of melioidosis. Braz J Microbiol. 2022;53(1):185–93.
  8. 8. Price EP, Dale JL, Cook JM. Development and Validation of Burkholderia pseudomallei- Specific Real-Time PCR Assays for Clinical, Environmental or Forensic Detection Bui Ngoc Hieu et al. DOI: https://doi.org/10.38148/JHDS.0901SKPT25-119
  9. 9. Houghton RL, Reed DE, Hubbard MA, et al. Development of a Prototype Lateral Flow Immunoassay (LFI) for the Rapid Diagnosis of Melioidosis. PLoS Negl Trop Dis. 2014;8(3):e2727.
  10. 10. Phokrai P, Karoonboonyanan W, Thanapattarapairoj N, et al. A Rapid Immunochromatography Test Based on Hcp1 Is a Potential Point-of-Care Test for Serological Diagnosis of Melioidosis. J Clin Microbiol. 2018;56(8):e00346-18.
  11. 11. Wagner GE, Föderl-Höbenreich E, Assig K, et al. Melioidosis DS rapid test: A standardized serological dipstick assay with increased sensitivity and reliability due to multiplex detection. PLoS Negl Trop Dis. 2020;14(7):e0008452.
  12. 12. T.T. Trinh, T.S. Hoang, D.A. Tran, et al. A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam. Clin Microbiol Infect. 2018;24(1):84.e1-84.e4.
  13. 13. Shaw T, Tellapragada C, Ke V, et al. Performance evaluation of Active Melioidosis Detect-Lateral Flow Assay (AMD-LFA) for diagnosis of melioidosis in endemic settings with limited resources. PLoS ONE. 2018;13(3):e0194595.
  14. 14. Peeters M, Chung P, Lin H, et al. Diagnostic accuracy of the InBiOS AMD rapid diagnostic test for the detection of Burkholderia pseudomallei antigen in grown blood culture broth. Eur J Clin Microbiol Infect Dis. 2018;37(6):1169–77.
  15. 15. Wongsuvan G, Hantrakun V, Teparrukkul P, et al. Sensitivity and specificity of a lateral flow immunoassay (LFI) in serum samples for diagnosis of melioidosis. Trans R Soc Trop Med Hyg. 2018;112:568–70.
  16. 16. Woods KL, Boutthasavong L, NicFhogartaigh C, et al. Evaluation of a Rapid Diagnostic Test for Detection of Burkholderia pseudomallei in the Lao People’s Democratic Republic. J Clin Microbiol. 2018;56(7):e02002-17.
  17. 17. Rizzi MC, Rattanavong S, Bouthasavong L, et al. Evaluation of the Active Melioidosis DetectTM test as a point-of-care tool for the early diagnosis of melioidosis: a comparison with culture in Laos. Trans R Soc Trop Med Hyg. 2019;113(12):757–63.
  18. 18. Amornchai P, Hantrakun V, Wongsuvan G, et al. Sensitivity and specificity of DPP® Fever Panel II Asia in the diagnosis of malaria, dengue and melioidosis. J Med Microbiol. 2022;71(8):001584.
  19. 19. Hara Y, Chin CY, Mohamed R, et al. Multiple- antigen ELISA for melioidosis - a novel approach to the improved serodiagnosis of melioidosis. BMC Infect Dis. 2013;13(1):165.
  20. 20. Suttisunhakul V, Chantratita N, Wikraiphat C, et al. Evaluation of Polysaccharide-Based Latex Agglutination Assays for the Rapid Detection of Antibodies to Burkholderia pseudomallei. Am J Trop Med Hyg. 2015;93(3):542–6.
  21. 21. Hii SYF, Ali NA, Ahmad N, et al. Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia. J Med Microbiol. 2017;66(11):1623–7.
  22. 22. Yatsomboon A, Sermswan RW, Wongratanacheewin S. Development of an immunomagnetic separation-ELISA for the detection of Burkholderia pseudomallei in blood samples. Asian Pac J Allergy Immunol. 2021;39(1):35–43.
  23. 23. Wajanarogana S, Taylor WRJ, Kritsiriwuthinan K. Enhanced serodiagnosis of melioidosis by indirect ELISA using the chimeric protein rGroEL-FLAG300 as an antigen. BMC Infect Dis. 2022;22(1):387.
  24. 24. Tandhavanant S, Wongsuvan G, Wuthiekanun V, et al. Monoclonal Antibody-Based Immunofluorescence Microscopy for the Rapid Identification of Burkholderia pseudomallei in Clinical Specimens. Am J Trop Med Hyg. 2013;89(1):165–8.
  25. 25. Chantratita N, Tandhavanant S, Wongsuvan G, et al. Rapid Detection of Burkholderia pseudomallei in Blood Cultures Using a Monoclonal Antibody-Based Immunofluorescent Assay. Am J Trop Med Hyg. 2013;89(5):971–2.
  26. 26. Dulsuk A, Paksanont S, Sangchankoom A. Validation of a monoclonal antibody-based immunofluorescent assay to detect Burkholderia pseudomallei in blood cultures. Trans R Soc Trop Med Hyg. 2017;670–2.
  27. 27. Settles EW, Sonderegger D, Shannon AB. Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis. PLoS Negl Trop Dis. 2023;17(2):e0011072.
  28. 28. Duval BD, Elrod MG, Gee JE. Evaluation of a Latex Agglutination Assay for the Identification of Burkholderia pseudomallei and Burkholderia mallei. Am J Trop Med Hyg. 2014;90(6):1043–
  29. 29. Muangsombut V, Withatanung P, Chantratita N, et al. Rapid Clinical Screening of Burkholderia Bui Ngoc Hieu et al. DOI: https://doi.org/10.38148/JHDS.0901SKPT25-119
  30. 30. Ali MRM, Huey LL, Foo PC, et al. Duplex TaqMan Hydrolysis Probe-Based Molecular Assay for Simultaneous Detection and Differentiation of Burkholderia pseudomallei and Leptospira spp. DNA. Biomed Res Int. 2019;2019:1–6.
  31. 31. Yadav PK, Suchetna Singh, Paul M, et al. Development of a novel sequence based real- time PCR assay for specific and sensitive detection of Burkholderia pseudomallei in clinical and environmental matrices. Ann Clin Microbiol Antimicrob. 2024;23(1):30.
  32. 32. Campbell S, Taylor B, Menouhos D, et al. Performance of MALDI-TOF MS, real- time PCR, antigen detection, and automated biochemical testing for the identification of Burkholderia pseudomallei. J Clin Microbiol. 2024;62(10):e00961-24.
  33. 33. Wang X, Wang L, Zhu H, et al. Reliable detection of Burkholderia pseudomallei using multiple cross displacement amplification label-based biosensor. BMC Microbiol. 2022;22(1):72.
  34. 34. Chua KH, Tan EW, Chai HC, et al. Rapid identification of melioidosis agent by an insulated isothermal PCR on a field–deployable device. PeerJ. 2020;8:e9238.
  35. 35. Amornchai P, Hantrakun V, Wongsuvan G, et al. Evaluation of antigen-detecting and antibody- detecting diagnostic test combinations for diagnosing melioidosis. PLoS Negl Trop Dis. 2021;15(11):e0009840.
  36. 36. Noparatvarakorn C, Sengyee S, Yarasai A. Prospective Analysis of Antibody Diagnostic Tests and TTS1 Real-Time PCR for Diagnosis of Melioidosis in Areas Where It Is Endemic. J Clin Microbiol. 2023;61(3):e01605-22.
  37. 37. Tran Thi Le Quyen, Nguyen Thi Tinh, Bui Nguyen Hai Linh, et al. Evaluation of the Recombinant Hemolysin Co-regulated Protein 1 (Hcp1) Antigen for Rapid Diagnosis of Melioidosis (Whitmore’s Disease) Using the ELISA Technique. Vietnam J Sci Technol. 2020;62(9):26–31.
  38. 38. Bui Thi Lan Anh, Pham Thi Ha Giang, Le Thi Lan Anh, et al. Development and Evaluation of the Sensitivity and Specificity of PCR and LAMP Techniques for the Detection of Burkholderia pseudomallei. Vietnam J Prev Med. 2021;30(3):55–62.
  39. 39. Hoang Viet Ha, Bui Nguyen Hai Linh, Tran Thi Le Quyen, et al. Comparison of Bacterial Identification Techniques for Burkholderia pseudomallei in the Diagnostic Testing of Whitmore’s Disease. Vietnam J Sci Technol. 2020;62(5):6–12. Bui Ngoc Hieu et al. DOI: https://doi.org/10.38148/JHDS.0901SKPT25-119